butylhydroxybutylnitrosamine has been researched along with Body Weight in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (40.82) | 18.7374 |
1990's | 20 (40.82) | 18.2507 |
2000's | 6 (12.24) | 29.6817 |
2010's | 3 (6.12) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, HL; Chen, YY; Chuang, JJ; Dai, YC; Lin, WH; Lin, YL; Liu, YW | 1 |
Chen, SS; Huang, CC; Lin, PY; Lin, YL; Liu, YW | 1 |
Kakehashi, A; Kato, M; Wanibuchi, H; Wei, M; Xie, XL; Yamano, S; Yunoki, T | 1 |
Eisenhardt, A; Lümmen, G; Otto, T; Rübben, H; Sperling, H; vom Dorp, F | 1 |
Furukawa, F; Hirose, M; Imazawa, T; Masegi, T; Nakamura, H; Nishikawa, A; Okazaki, K; Son, HY; Yamagishi, M | 1 |
Asamoto, M; Hikosaka, A; Kohri, K; Nakanishi, M; Ogawa, K; Sato, SY; Shirai, T; Sugiura, S; Takeshita, F | 1 |
Habs, M; Schmähl, D; Tacchi, AM | 1 |
Fukushima, S; Hirose, M; Inui, M; Ito, N; Sakata, T | 1 |
Fukushima, S; Ikawa, E; Ito, N; Kurata, Y; Shibata, M | 2 |
Fukushima, S; Hagiwara, A; Ito, N; Ogiso, T; Shibata, M | 1 |
Babaya, K; Hiramatsu, T; Hirao, Y; Ijuin, M; Kihoin, K; Maruyama, Y; Ohara, S; Okajima, E; Tanaka, M | 1 |
Hicks, RM; James, C; Webbe, G | 1 |
Hasegawa, R; Ito, N; Nagao, M; Shirai, T; Sugimura, T; Tamano, S; Tanaka, H | 1 |
Fukushima, S; Hayashi, Y; Hosono, M; Makino, S; Mori, S; Murai, T; Ohhara, T; Takeda, R; Takeuchi, Y | 1 |
Kojima, T; Mori, H; Morishita, Y; Okumura, A; Suzui, M; Tanaka, T | 1 |
Akagi, K; Hara, Y; Hirose, M; Hoshiya, T; Ito, N; Takahashi, S | 1 |
Fukushima, S; Hosono, M; Machino, S; Makino, S; Matsuda, T; Mori, S; Murai, T; Oohara, T; Takashima, A; Wanibuchi, H; Yamashita, H | 1 |
Chou, C; Fukushima, S; Hosono, M; Machino, S; Makino, S; Mori, S; Murai, T | 1 |
Akai, H; Denda, A; Kitayama, W; Konishi, Y; Okajima, E; Ozono, S; Sasaki, Y; Takahama, M; Wakabayashi, K | 1 |
Sato, D | 1 |
Fukushima, S; Goshima, H; Hagiwara, A; Mori, S; Murai, T; Shirai, T; Takashima, A; Yoshino, H | 1 |
Barbisan, LF; Fávero Salvadori, DM; Kaneno, R; Marchesan Rodrigues, MA; Spinardi-Barbisan, AL; Trindade Moreira, EL; Viana de Camargo, JL | 1 |
Fukushima, S; Kishimoto, T; Masuda, C; Otani, S; Sekine, K; Tsuda, H; Wanibuchi, H; Yano, Y | 1 |
Futakuchi, M; Hirose, M; Iwata, T; Kasai, M; Kimoto, N; Shirai, T | 1 |
Hashimoto, Y; Okada, M; Suzuki, E | 1 |
Fukushima, S; Hananouchi, M; Hirose, M; Ogiso, T; Shirai, T | 1 |
Fukushima, S; Kurata, Y; Ono, S; Sano, M; Shichino, Y | 1 |
Fukushima, S; Kawabe, M; Mori, Y; Ni-I, H; Okada, M; Shirai, T; Tamano, S | 1 |
Fukushima, S; Hasegawa, R; Sano, M; Shibata, MA; Shirai, T | 1 |
Asamoto, M; de Camargo, JL; Fukushima, S; Kato, T; Shirai, T | 1 |
Fukushima, S; Hayashi, Y; Hosono, M; Makino, S; Mori, S; Murai, T; Ohara, T; Takeda, R; Takeuchi, Y | 1 |
Aso, Y; Homma, Y; Kakizoe, T; Kondo, Y; Nagase, S | 1 |
Akaza, H; Aso, Y; Koiso, K; Matsuki, K; Matsushima, H | 1 |
Hagiwara, A; Hayashi, Y; Hosono, M; Kurata, Y; Makino, S; Mori, S; Murai, T; Ohhara, T; Shibata, MA; Takeuchi, Y | 1 |
Chappel, CI; Cohen, SM; Ellwein, LB; Johansson, SL; Khachab, M; Masui, T; Okamura, T; Schoenig, GP; Smith, RA; Wehner, JM | 1 |
Asamoto, M; Fukushima, S; Ogiso, T; Okumura, M; Shirai, T | 1 |
Asakawa, E; Fukushima, S; Hagiwara, A; Ogiso, T; Tamano, S | 1 |
Fukushima, S; Imaida, K; Ito, N; Nagase, S; Nakanowatari, J | 1 |
Fukushima, S; Masui, T; Mutai, M; Shirai, T; Takahashi, S | 1 |
Hirao, Y; Iwata, H; Matsuki, H; Okajima, E; Ozono, S; Sasaki, K; Takahashi, S; Tsunemi, K | 1 |
Fukushima, S; Imaida, K; Inoue, T; Okada, M; Suzuki, E | 1 |
Fukushima, S; Imaida, K; Kurata, Y; Shibata, M; Shirai, T; Tamano, S | 1 |
Ito, N; Masui, T; Miyata, Y; Nakanishi, K; Shibata, M; Shibata, MA | 1 |
Fukushima, S; Hirose, M; Ito, N; Kurata, Y; Ogiso, T | 1 |
Hiasa, Y; Kitahori, Y; Konishi, N; Miyashiro, A; Shimoyama, T | 1 |
Hiasa, Y; Kitahori, Y; Konishi, N; Shimoyama, T | 1 |
Fukushima, S; Ito, N; Shibata, MA; Shirai, T; Tamano, S | 1 |
Fukushima, S; Ito, N; Kurata, Y; Miyata, Y; Ogiso, T; Okuda, M | 1 |
49 other study(ies) available for butylhydroxybutylnitrosamine and Body Weight
Article | Year |
---|---|
Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Cell Line, Tumor; Coloring Agents; Decitabine; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Female; Glutathione Transferase; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mucous Membrane; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Urinary Bladder; Urinary Bladder Neoplasms | 2014 |
Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice.
Topics: Animals; Antioxidants; Arsenites; Blotting, Western; Body Weight; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Cytosine; Deoxyguanosine; DNA Damage; DNA Methylation; Drug Synergism; Female; Mice; Mice, Inbred C57BL; Sp1 Transcription Factor; Urinary Bladder; Urinary Bladder Neoplasms; Water Pollutants, Chemical | 2012 |
Long-term treatment with L-isoleucine or L-leucine in AIN-93G diet has promoting effects on rat bladder carcinogenesis.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Diet; Dietary Supplements; Hydrogen-Ion Concentration; Isoleucine; Leucine; Male; Papilloma; Rats; Rats, Inbred F344; Urinalysis; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2012 |
Influence of pertussis toxin on superficial bladder carcinoma in rats.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Female; Pertussis Toxin; Rats; Rats, Wistar; Urinary Bladder Neoplasms; Urine | 2002 |
Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Butylhydroxybutylnitrosamine; Isothiocyanates; Male; Organ Size; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 2002 |
Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
Topics: Animals; Base Sequence; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; DNA Primers; Female; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Urinary Bladder Neoplasms | 2008 |
Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna).
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Drinking; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Nitrosamines; Rats; Rats, Inbred Strains; Time Factors; Urinary Bladder Neoplasms | 1984 |
Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Diet; Flavonoids; Hyperplasia; Male; Nitrosamines; Papilloma; Quercetin; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1983 |
Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats.
Topics: Animals; Biphenyl Compounds; Body Weight; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Male; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1983 |
Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
Topics: Acetazolamide; Allopurinol; Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Hyperplasia; Male; Neoplasms, Experimental; Nitrosamines; Quercetin; Rats; Rats, Inbred F344; Saccharin; Tryptophan; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Cocarcinogenesis; Electrolytes; Ethoxyquin; Hydrogen-Ion Concentration; Hyperplasia; Male; Nitrosamines; Organ Size; Osmolar Concentration; Papilloma; Quinolines; Rats; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
[Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Butylhydroxybutylnitrosamine; Fluorouracil; Male; Neoplasms, Experimental; Organ Size; Rats; Rats, Inbred Strains; Tegafur; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Hematocrit; Male; Neoplasms, Experimental; Nitrosamines; Papio; Schistosoma haematobium; Schistosomiasis; Ureter; Urinary Bladder; Urinary Bladder Neoplasms | 1980 |
Synergistic enhancement of small and large intestinal carcinogenesis by combined treatment of rats with five heterocyclic amines in a medium-term multi-organ bioassay.
Topics: 1,2-Dimethylhydrazine; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Diethylnitrosamine; Dimethylhydrazines; Dose-Response Relationship, Drug; Drug Synergism; Imidazoles; Intestinal Neoplasms; Male; Methylnitrosourea; Nitrosamines; Organ Size; Rats; Rats, Inbred F344 | 1994 |
Influences of aging and sex on renal pelvic carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Topics: Aging; Animals; Body Weight; Butylhydroxybutylnitrosamine; Female; Kidney Neoplasms; Kidney Pelvis; Male; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Sex Factors; Urinary Bladder Neoplasms | 1994 |
Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin.
Topics: Animals; Anticarcinogenic Agents; beta Carotene; Body Weight; Butylhydroxybutylnitrosamine; Canthaxanthin; Carotenoids; Liver; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Organ Size; Precancerous Conditions; Silver Staining; Urinary Bladder Neoplasms; Xanthophylls | 1994 |
Effects of green tea catechins in a rat multi-organ carcinogenesis model.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Catechin; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Intestinal Neoplasms; Intestine, Small; Kidney Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Models, Biological; Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1993 |
Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Male; Organ Size; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Species Specificity; Survival Rate; Urinary Bladder; Urinary Bladder Neoplasms; Water Supply | 1997 |
Lack of promotion of urinary bladder carcinogenesis by sodium bicarbonate and/or L-ascorbic acid in male ODS/Shi-od/od rats synthesizing alpha 2 mu-globulin but not L-ascorbic acid.
Topics: alpha-Macroglobulins; Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cocarcinogenesis; Drug Combinations; Eating; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred F344; Rats, Mutant Strains; Sodium; Sodium Bicarbonate; Urinalysis; Urinary Bladder Neoplasms | 1997 |
Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cyclooxygenase Inhibitors; Eating; Incidence; Male; Organ Size; Rats; Rats, Inbred F344; Sulfonamides; Urinary Bladder Neoplasms | 1998 |
Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Male; Papilloma; Rats; Rats, Wistar; Tea; Urinary Bladder Neoplasms | 1999 |
Hepatocarcinogenic activity of N-butyl-N-(4-hydroxybutyl)nitrosamine in rats is not modified by sodium L-ascorbate.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Female; Liver; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344; Rats, Wistar | 1999 |
Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats.
Topics: 1,2-Dimethylhydrazine; 2-Acetylaminofluorene; Alkylating Agents; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Carcinogens; Concanavalin A; Diethylnitrosamine; Flow Cytometry; Male; Methylnitrosourea; Neoplasms, Experimental; Nitrosamines; Phenobarbital; Rats; Rats, Wistar; Spleen; T-Lymphocyte Subsets; Tissue Distribution | 2000 |
Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Topics: Acetyltransferases; Animals; Anticarcinogenic Agents; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Cattle; Chlorides; Drinking; Eating; Hydrogen-Ion Concentration; Lactoferrin; Liver; Male; Mucous Membrane; Organ Size; Ornithine Decarboxylase; Potassium; Rats; Rats, Inbred F344; Sodium; Urinary Bladder; Urinary Bladder Neoplasms | 2000 |
Site-dependent modulating effects of conjugated fatty acids from safflower oil in a rat two-stage carcinogenesis model in female Sprague-Dawley rats.
Topics: 1,2-Dimethylhydrazine; 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Dietary Supplements; Dose-Response Relationship, Drug; Fatty Acids; Female; Glutathione Transferase; Hyperplasia; Linoleic Acid; Mammary Neoplasms, Experimental; Neoplasms; Nitrosamines; Organ Size; Phosphorylation; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Safflower Oil; Time Factors; Urinary Bladder Neoplasms | 2001 |
Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Hepatocellular; Liver Neoplasms; Male; Nitrosamines; Rats; Rats, Inbred ACI; Urinary Bladder Neoplasms | 1976 |
Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cricetinae; Guinea Pigs; Male; Mice; Nitrosamines; Organ Size; Papilloma; Propionates; Rats; Sarcoma; Urinary Bladder Neoplasms | 1976 |
Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; DNA, Neoplasm; Drug Synergism; Environmental Pollutants; Feeding Behavior; Male; Organ Size; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1992 |
Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma in Situ; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Male; Mice; Mice, Nude; Nitrosamines; Urinary Bladder Neoplasms; Urodynamics | 1992 |
Timing effects of uracil-induced urolithiasis on amplification of second-stage promotion in rat bladder carcinogenesis.
Topics: Animals; Bicarbonates; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Drug Administration Schedule; Male; Rats; Rats, Inbred F344; Sodium; Sodium Bicarbonate; Uracil; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Calculi | 1991 |
Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Ascorbic Acid; Body Weight; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Butylhydroxybutylnitrosamine; Carcinogens; Epithelium; Ethoxyquin; Male; Mucous Membrane; Organ Size; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Uracil; Urinary Bladder; Urinary Bladder Neoplasms | 1991 |
Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Topics: Abdominal Neoplasms; Animals; Body Weight; Butylhydroxybutylnitrosamine; Disease Models, Animal; Hydronephrosis; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Urinary Bladder Neoplasms | 1991 |
Lack of bladder carcinogenicity of dietary sodium saccharin in analbuminaemic rats, which are highly susceptible to N-nitroso-n-butyl-(4-hydroxybutyl)amine.
Topics: Administration, Oral; Animals; Body Weight; Butylhydroxybutylnitrosamine; Disease Susceptibility; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred Strains; Saccharin; Serum Albumin; Sodium; Species Specificity; Urinary Bladder Neoplasms | 1991 |
Stimulatory effects of growth hormone on rat bladder carcinogenesis.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Growth Hormone; Male; Rats; Rats, Inbred Strains; Recombinant Proteins; Time Factors; Urinary Bladder Neoplasms | 1991 |
No promotion of urinary bladder carcinogenesis by sodium L-ascorbate in male ODS/Shi-od/od rats lacking L-ascorbic acid-synthesizing ability.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Epithelium; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred F344; Rats, Inbred Strains; Sodium; Urinary Bladder Neoplasms | 1991 |
Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Calcium Carbonate; Diet; Drinking; Drug Synergism; FANFT; Hydrogen-Ion Concentration; Kidney; Male; Rats; Rats, Inbred F344; Saccharin; Urinary Bladder; Urinary Bladder Neoplasms; Urine | 1991 |
Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Kidney Neoplasms; Kidney Pelvis; Male; Organ Size; Papilloma; Rats; Rats, Inbred F344; Uracil; Urinary Bladder Neoplasms | 1991 |
Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Clofibrate; Diethylhexyl Phthalate; DNA, Neoplasm; Liver; Male; Organ Size; Rats; Rats, Inbred F344; Uracil; Urinary Bladder Neoplasms | 1990 |
Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Cytochrome b Group; Cytochrome P-450 Enzyme System; Cytochromes b5; Disease Susceptibility; Epithelium; Neoplasms, Experimental; Nitrosamines; Organ Size; Rats; Rats, Inbred ACI; Rats, Inbred F344; Rats, Inbred Strains; Species Specificity; Urinary Bladder; Urinary Bladder Neoplasms | 1988 |
Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Body Weight; Butylated Hydroxyanisole; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Division; Cocarcinogenesis; Hyperplasia; Male; Nitrosamines; Papilloma; Rats; Rats, Inbred F344; Uracil; Urinary Bladder; Urinary Bladder Neoplasms | 1988 |
Effect of 1-hexylcarbamoyl-5-fluorouracil on development of rat urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Antineoplastic Agents; Body Weight; Butylhydroxybutylnitrosamine; Fluorouracil; Male; Nitrosamines; Organ Size; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1988 |
Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Citrates; Citric Acid; Diethylnitrosamine; Drug Interactions; Hydrogen-Ion Concentration; Male; Nitrosamines; Organ Size; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1988 |
Promotion by L-ascorbic acid of urinary bladder carcinogenesis in rats under conditions of increased urinary K ion concentration and pH.
Topics: Animals; Ascorbic Acid; Body Weight; Butylhydroxybutylnitrosamine; Hydrogen-Ion Concentration; Male; Organ Size; Potassium; Rats; Rats, Inbred F344; Sodium; Urinary Bladder Neoplasms | 1987 |
Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinoma; Cocarcinogenesis; Hyperplasia; Male; Nitrosamines; Papilloma; Rats; Rats, Inbred F344; Sodium Chloride; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Topics: Animals; Body Weight; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Dose-Response Relationship, Drug; Ethoxyquin; Ligation; Male; Quinolines; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Acetates; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Drug Synergism; Hyperplasia; Male; Nitrilotriacetic Acid; Nitrosamines; Organ Size; Papilloma; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1985 |
Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Acetates; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Kidney; Male; Nitrilotriacetic Acid; Organ Size; Papilloma; Precancerous Conditions; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1985 |
Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats.
Topics: Animals; Ascorbic Acid; Bicarbonates; Body Weight; Butylhydroxybutylnitrosamine; Dehydroascorbic Acid; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred F344; Sodium; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Pathological analysis of the carcinogenicity of sodium o-phenylphenate and o-phenylphenol.
Topics: Animals; Biphenyl Compounds; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Cocarcinogenesis; Hyperplasia; Male; Microscopy, Electron, Scanning; Microvilli; Organ Size; Papilloma; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1985 |